Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients

Molecular Medicine

Zhibin Han¹  Zhenfeng Jiang¹  Zhiguo Lin¹  Xingbo Cheng¹  Wang Zhang¹  Zhishuai Ren²  Bo Zhang²  Xiaoyu Lian²  Lu Bian²  Jialin Wang²  Hongbo Wang²  Yanbiao Wang²  Binfeng Liu²  Yanzheng Gao³  Zhendong Liu³ 

[1] Department of Neurosurgery, The First Affiliate Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, 150001, Harbin, China;Department of Orthopaedics, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, China;Department of Orthopaedics, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, School of Clinical Medicine, Henan University, Zhengzhou, Henan, China;Microbiology Laboratory, Henan Provincial People’s Hospital, Zhengzhou, China;

关键词: Glioma;    XRCC2;    Oncogene;    Prognosis;    Biomarker;   

DOI  :  10.1186/s10020-021-00316-0

来源: Springer

【 授权许可】

CC BY